Approval · Notice of Compliance 5474 · 1994
PERMAX: Notice of Compliance 5474
Issued August 12, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5474
- Date
- August 12, 1994
- Company
- Draxis Health Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Dopamine agonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PERMAX | 02123320 | — |
| PERMAX | 02123339 | — |
| PERMAX | 02123347 | — |
Medicinal ingredients
- PERGOLIDE MESYLATE 0.05 MG per TAB
- PERGOLIDE MESYLATE 0.25 MG per TAB
- PERGOLIDE MESYLATE 1 MG per TAB